Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.66
-0.08-4.60%
At close: -
$1.81
0.159.04%
After Hours: May 30, 8:26 AM EDT
Comments
Loading...
ProQR Therapeutics (PRQR) Forecast
NewsEarningsProQR Therapeutics (PRQR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
ProQR Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PRQR | Benzinga
Explore ProQR Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRQR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ProQR Therapeutics (PRQR) stock?
You can purchase shares of ProQR Therapeutics (NASDAQ:PRQR) through any online brokerage.
Who are ProQR Therapeutics (PRQR) competitors?
There are no as such competitors for ProQR Therapeutics.
What is the forecast, or price target, for ProQR Therapeutics (PRQR) stock?
ProQR Therapeutics has a consensus price target of $7.72.
What is the current price for ProQR Therapeutics (PRQR)?
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.81 last updated May 30, 2025 at 8:26 AM EDT.
Does ProQR Therapeutics (PRQR) pay a dividend?
There are no upcoming dividends for ProQR Therapeutics.
When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?
ProQR Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is ProQR Therapeutics (PRQR) going to split?
There is no upcoming split for ProQR Therapeutics.
What sector and industry does ProQR Therapeutics (PRQR) operate in?
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
